{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:27:40Z","timestamp":1790220460222,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"British Hearth Foundation","award":["PG\/06\/153\/22042"],"award-info":[{"award-number":["PG\/06\/153\/22042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.bcp.2009.09.015","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T09:04:04Z","timestamp":1253178244000},"page":"525-534","source":"Crossref","is-referenced-by-count":50,"title":["From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?"],"prefix":"10.1016","volume":"79","author":[{"given":"Fulvio","family":"D\u2019Acquisto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Pederzoli-Ribeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.09.015_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.09.015_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1096\/fj.06-7227rev","article-title":"Resolution of inflammation: state of the art, definitions and terms","volume":"21","author":"Serhan","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2009.09.015_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08916930801929021","article-title":"Molecular mechanisms of autoimmunity","volume":"41","author":"Atassi","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V88.1.230.230","article-title":"Activation of naive and memory T cells by interleukin-15","volume":"88","author":"Kanegane","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.09.015_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm1615","article-title":"IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities","volume":"13","author":"Orinska","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1074-7613(00)80246-0","article-title":"IL-15: a pleiotropic cytokine with diverse receptor\/signaling pathways whose expression is controlled at multiple levels","volume":"4","author":"Tagaya","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib9","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1073\/pnas.94.26.14444","article-title":"Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides","volume":"94","author":"Tagaya","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.09.015_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1615\/CritRevImmunol.v18.i6.20","article-title":"The structure and function of gamma c-dependent cytokines and receptors: regulation of T lymphocyte development and homeostasis","volume":"18","author":"He","year":"1998","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4049\/jimmunol.158.1.255","article-title":"Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms","volume":"158","author":"Onu","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.0610115104","article-title":"The IL-15\/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells","volume":"104","author":"Sato","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.09.015_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.185.3.499","article-title":"Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain","volume":"185","author":"Suzuki","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib14","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.0307442101","article-title":"Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression","volume":"101","author":"Schluns","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.09.015_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.181.3.1255","article-title":"Chemoattraction of human blood T lymphocytes by interleukin-15","volume":"181","author":"Wilkinson","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib16","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood.V90.7.2804","article-title":"Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes","volume":"90","author":"Badolato","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.09.015_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.09.015_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-5699(97)01205-X","article-title":"Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis","volume":"19","author":"McInnes","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.bcp.2009.09.015_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.bcp.2009.09.015_bib20","doi-asserted-by":"crossref","first-page":"iii26","DOI":"10.1136\/ard.2008.098004","article-title":"Th17 cells in immunity and autoimmunity","volume":"67","author":"Oukka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2009.09.015_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","article-title":"An overview of IL-17 function and signaling","volume":"43","author":"Gaffen","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2009.09.015_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cr.2008.320","article-title":"IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling","volume":"19","author":"Rong","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.bcp.2009.09.015_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","article-title":"The roles of IL-17A in inflammatory immune responses and host defense against pathogens","volume":"226","author":"Iwakura","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib25","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.161.11.6383","article-title":"IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines","volume":"161","author":"Schwarzenberger","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bcp.2008.11.011","article-title":"Interleukin 17 sustains rather than induces inflammation","volume":"77","author":"Maione","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.09.015_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: from precursors to players in inflammation and infection","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00712.x","article-title":"Th17 cytokines and their emerging roles in inflammation and autoimmunity","volume":"226","author":"Fouser","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.20072066","article-title":"A rush to judgment on Th17","volume":"205","author":"Steinman","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cytogfr.2007.06.024","article-title":"The tale of soluble receptors and binding proteins: from bench to bedside","volume":"18","author":"Novick","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1189\/jlb.0503230","article-title":"Generation and characterization of mice transgenic for human IL-18-binding protein isoform a","volume":"74","author":"Fantuzzi","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2009.09.015_bib34","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/stke.2003.171.re3","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: signal transduction during inflammation and host defense","volume":"2003","author":"Dunne","year":"2003","journal-title":"Sci STKE"},{"key":"10.1016\/j.bcp.2009.09.015_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jlb.63.6.650","article-title":"Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants","volume":"63","author":"O\u2019Neill","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2009.09.015_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ni1377","article-title":"Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation","volume":"7","author":"Gutcher","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib37","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1111\/j.1600-6143.2006.01536.x","article-title":"Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection","volume":"6","author":"Wyburn","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bcp.2009.09.015_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0952-7915(99)00051-5","article-title":"The role of IL-18 in innate immunity","volume":"12","author":"Akira","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60389-2","article-title":"Interleukin-18: a novel cytokine that augments both innate and acquired immunity","volume":"70","author":"Okamura","year":"1998","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1286-4579(00)01279-X","article-title":"Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens","volume":"2","author":"Sugawara","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bcp.2009.09.015_bib41","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1099\/vir.0.19120-0","article-title":"IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system","volume":"84","author":"Gherardi","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bcp.2009.09.015_bib42","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.4049\/jimmunol.162.9.5070","article-title":"IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib43","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J","article-title":"IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background","volume":"30","author":"Xu","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib44","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.4049\/jimmunol.164.5.2701","article-title":"IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma","volume":"164","author":"Wild","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib45","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U","article-title":"In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells","volume":"30","author":"Hoshino","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib46","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.4049\/jimmunol.166.12.7014","article-title":"Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function","volume":"166","author":"Hoshino","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semnephrol.2006.09.013","article-title":"Interleukin-18 and the pathogenesis of inflammatory diseases","volume":"27","author":"Dinarello","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.bcp.2009.09.015_bib48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.gt.3301986","article-title":"Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice","volume":"10","author":"Smeets","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.bcp.2009.09.015_bib49","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.170.4.2100","article-title":"Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein","volume":"170","author":"Banda","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.09.015_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1688","article-title":"Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation","volume":"5","author":"Leonard","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00201.x","article-title":"Biology of IL-21 and the IL-21 receptor","volume":"202","author":"Mehta","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/IR:28:2:131","article-title":"IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity","volume":"28","author":"Collins","year":"2003","journal-title":"Immunol Res"},{"key":"10.1016\/j.bcp.2009.09.015_bib54","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI27727","article-title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation","volume":"116","author":"Pesce","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2009.09.015_bib55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2008.01.041","article-title":"Regulation of gut inflammation and th17 cell response by interleukin-21","volume":"134","author":"Fina","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2009.09.015_bib56","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.09.015_bib57","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6","volume":"173","author":"Ozaki","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib58","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.4049\/jimmunol.0803009","article-title":"IL-21: an executor of B cell fate","volume":"182","author":"Konforte","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-065X.2008.00631.x","article-title":"The role of IL-21 in regulating B-cell function in health and disease","volume":"223","author":"Ettinger","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib60","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2003-03-0669","article-title":"Interleukin-21 inhibits dendritic cell activation and maturation","volume":"102","author":"Brandt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.09.015_bib61","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","article-title":"IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells","volume":"37","author":"Fantini","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib63","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1182\/blood-2006-09-045278","article-title":"Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV)","volume":"109","author":"White","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.09.015_bib64","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.200324533","article-title":"IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors","volume":"33","author":"Sivori","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(02)00295-9","article-title":"IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity","volume":"16","author":"Kasaian","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib66","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","article-title":"IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression","volume":"178","author":"Herber","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib67","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.4049\/jimmunol.0804350","article-title":"A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25\u2212 T cell expansion is essential for the development of arthritis in autoimmune K\/BxN mice","volume":"182","author":"Jang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib68","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.22452","article-title":"Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis","volume":"56","author":"Young","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2009.09.015_bib69","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.174.5.2696","article-title":"Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen","volume":"174","author":"Vollmer","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0083-6729(06)74004-3","article-title":"Interleukin-22 and its crystal structure","volume":"74","author":"Nagem","year":"2006","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bcp.2009.09.015_bib71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","article-title":"Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells","volume":"17","author":"Wolk","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib72","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/eji.200838655","article-title":"IL-22 and inflammation: leukin\u2019 through a glass onion","volume":"38","author":"Zenewicz","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib73","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00109-009-0448-1","article-title":"IL-22: a critical mediator in mucosal host defense","volume":"87","author":"Aujla","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.09.015_bib77","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2009.09.015_bib78","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2009.09.015_bib79","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/107999001317205178","article-title":"Acinar cells of the pancreas are a target of interleukin-22","volume":"21","author":"Aggarwal","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.bcp.2009.09.015_bib80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.intimp.2004.01.008","article-title":"Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells","volume":"4","author":"Nagalakshmi","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bcp.2009.09.015_bib81","first-page":"43","article-title":"Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3","volume":"1","author":"Pan","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bcp.2009.09.015_bib84","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib85","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib86","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2009.09.015_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1189\/jlb.0602326","article-title":"A unique role for IL-23 in promoting cellular immunity","volume":"73","author":"Lankford","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2009.09.015_bib88","doi-asserted-by":"crossref","first-page":"PE1","DOI":"10.1126\/stke.2002.114.pe1","article-title":"IL-23: a cytokine that acts on memory T cells","volume":"2002","author":"Frucht","year":"2002","journal-title":"Sci STKE"},{"key":"10.1016\/j.bcp.2009.09.015_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-065X.2008.00715.x","article-title":"Reconciling id, ego, and superego within interleukin-23","volume":"226","author":"Tato","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib91","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI200319079","article-title":"IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis","volume":"112","author":"Becher","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2009.09.015_bib92","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2009.09.015_bib93","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00714.x","article-title":"From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited","volume":"226","author":"Boniface","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","article-title":"Autoimmune inflammation from the Th17 perspective","volume":"6","author":"Furuzawa-Carballeda","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib95","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2353\/ajpath.2006.050228","article-title":"Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis","volume":"168","author":"Leithauser","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2009.09.015_bib96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.immuni.2008.02.019","article-title":"Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis","volume":"28","author":"Izcue","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib97","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.3748\/wjg.v13.i42.5547","article-title":"Emerging role of IL-23\/IL-17 axis in H pylori-associated pathology","volume":"13","author":"Caruso","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2009.09.015_bib98","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1053\/j.gastro.2009.02.049","article-title":"Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut","volume":"136","author":"Caruso","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2009.09.015_bib99","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1572-0241.2007.01661.x","article-title":"Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children","volume":"103","author":"Amre","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bcp.2009.09.015_bib100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ibd.20126","article-title":"IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease","volume":"13","author":"Dubinsky","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bcp.2009.09.015_bib101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib102","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00109-007-0164-7","article-title":"The biology and therapeutic potential of interleukin 27","volume":"85","author":"Batten","year":"2007","journal-title":"J Mol Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-065X.2008.00710.x","article-title":"Regulation of immune responses by interleukin-27","volume":"226","author":"Yoshida","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","article-title":"Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation","volume":"25","author":"Kastelein","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib106","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.4049\/jimmunol.174.12.7684","article-title":"Positive and negative regulation of the IL-27 receptor during lymphoid cell activation","volume":"174","author":"Villarino","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-7613(01)00206-0","article-title":"WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection","volume":"15","author":"Yoshida","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(03)00298-X","article-title":"WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production","volume":"19","author":"Hamano","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib109","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1074-7613(03)00300-5","article-title":"The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection","volume":"19","author":"Villarino","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.1508","article-title":"Expression of IL-27 in human Th1-associated granulomatous diseases","volume":"202","author":"Larousserie","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2009.09.015_bib111","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.4049\/jimmunol.173.9.5626","article-title":"The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity","volume":"173","author":"Artis","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib112","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20060471","article-title":"Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27","volume":"203","author":"Wirtz","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2009.09.015_bib113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2005.10.004","article-title":"An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor","volume":"23","author":"Dinarello","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines","volume":"223","author":"Arend","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2009.09.015_bib115","doi-asserted-by":"crossref","first-page":"pe31","DOI":"10.1126\/stke.3902007pe31","article-title":"IL-33: a sheep in wolf's clothing?","volume":"2007","author":"Gadina","year":"2007","journal-title":"Sci STKE"},{"key":"10.1016\/j.bcp.2009.09.015_bib116","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.09.015_bib117","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2009.09.015_bib118","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1432-1327.1999.00615.x","article-title":"Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells","volume":"264","author":"Iwahana","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2009.09.015_bib120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/bbrc.1999.1469","article-title":"Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7\/GM","volume":"264","author":"Tominaga","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2009.09.015_bib121","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2009.03.021","article-title":"Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation","author":"Bruneau","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bcp.2009.09.015_bib122","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1373\/clinchem.2007.096560","article-title":"Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure","volume":"54","author":"Mueller","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.bcp.2009.09.015_bib123","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2009.09.015_bib124","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2009.09.015_bib126","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.09.015_bib127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","article-title":"A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2","volume":"173","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib128","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.4049\/jimmunol.166.11.6633","article-title":"A novel pathway regulating lipopolysaccharide-induced shock by ST2\/T1 via inhibition of Toll-like receptor 4 expression","volume":"166","author":"Sweet","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.09.015_bib129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2009.09.015_bib130","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell\u2013leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209007692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209007692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T06:56:26Z","timestamp":1739343386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209007692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0006295209007692"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.09.015","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}